Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug;3(3):198-202.
doi: 10.3978/j.issn.2227-684X.2013.10.01.

Management of recurrent epithelial ovarian cancer

Víctor Manuel Vargas-Hernández  1 , Mario Adan Moreno-Eutimio  1 , Gustavo Acosta-Altamirano  1 , Víctor Manuel Vargas-Aguilar  1
Affiliations
Review

Management of recurrent epithelial ovarian cancer

Víctor Manuel Vargas-Hernández et al. Gland Surg. 2014 Aug.

Abstract

Epithelial ovarian cancer is the fifth most common cancer in women. It is usually diagnosed at an advanced stage and is the leading cause of death from gynecologic cancers in women. The overall survival rate at five years is 50% and its treatment is still poor. We need new treatments for patients with recurrent ovarian cancer who are incurable with current management. We review the effectiveness of new biological agents and morbidity and mortality of cytoreductive surgery. Since the hyperthermic increases the effectiveness of chemotherapy and the chance of survival, hyperthermic intraperitoneal chemotherapy has been proven to be a promising option, however it still requires further study to be the standard treatment.

Keywords: Epithelial ovarian cancer; biological agents; cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; morbidity and mortality.

PubMed Disclaimer

References

    1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108 - PubMed
    1. National Cancer Institute. SEER stat fact sheets: ovary. Bethesda, MD: National Cancer Institute; [cited 2013 June 14]. Available online: http://seer.cancer.gov/statfacts/html/ovary.html
    1. Vargas-Hernández VM, Hernández Rubio A, Reynoso Pablos R. Cáncer epitelial de ovario. Vargas-Hernández VM. 1ª. ed. Cáncer en la Mujer, Edit. Alfil México, 2011:1053-77.
    1. Helm CW. Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer. Surg Oncol Clin N Am 2012;21:645-63 - PubMed
    1. Barber EL, Zsiros E, Lurain JR, et al. The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer. J Gynecol Oncol 2013;24:258-64 - PMC - PubMed